Abstract:Background. MicroRNAs (miRNAs) have been found in virtually all body fluids and used successfully as biomarkers for various diseases. Evidence indicates that miRNAs have important roles in IgA nephropathy (IgAN), a major cause of renal failure. In this study, we looked for differentially expressed miRNAs in IgAN and further evaluated the correlations between candidate miRNAs and the severity of IgAN.Methods. Microarray and RT-qRCR (real-time quantitative polymerase chain reaction) were sequentially used to screen and further verify miRNA expression profiles in urinary sediments of IgAN patients in two independent cohorts. The screening cohort consisted of 32 urine samples from18 patients with IgAN, 4 patients with MN (membranous nephropathy), 4 patients with MCD (minimal changes disease) and 6 healthy subjects; the validation cohort consisted of 102 IgAN patients, 41 MN patients, 27 MCD patients and 34 healthy subjects. The renal pathological lesions of patients with IgAN were evaluated according to Lee's grading system and Oxford classification.Results. At the screening phase, significance analysis of microarrays analysis showed that no miRNA was differentially expressed in the IgAN group compared to all control groups. But IgAN grade I-II and III subgroups (according to Lee's grading system) shared dysregulation of two miRNAs (miR-3613-3p and miR-4668-5p). At the validation phase, RT-qPCR results showed that urinary level of miR-3613-3p was significantly lower in IgAN than that in MN, MCD and healthy controls (0.47, 0.44 and 0.24 folds, respectively, all P < 0.01 by Mann-Whitney U test); urinary level of miR-4668-5p was also significantly lower in IgAN than that in healthy controls (0.49 fold, P < 0.01). Significant correlations were found between urinary levels of miR-3613-3p with 24-hour urinary protein excretion (Spearman r = 0.50, P = 0.034), eGFR (estimated glomerular filtration rate) (r = -0.48, P = 0.043) and Lee's grades (r = 0.57, P = 0.014). Similarly, miR-4668-5p was significantly correlated with eGFR (r = -0.50, P = 0.034) and Lee's grades (r = 0.57, P = 0.013). For segmental glomerulosclerosis according to Oxford classification, patients scored as S0 had significantly lower levels of urinary miR-3613-3p and miR-4668-5p than those scored as S1 (0.41 and 0.43 folds, respectively, all P < 0.05).Conclusions. The expression profile of miRNAs was significantly altered in urinary sediments from patients with IgAN. Urinary expression of miR-3613-3p was down-regulated in patients with IgAN. Moreover, urinary levels of both miR-3613-3p and miR-4668-5p were correlated with disease severity. Further studies are needed to explore the roles of miR-3613-3p and miR-4668-5p in the pathogenesis and progression of IgA nephropathy.

Detection of miRNA in kidney biopsies of child patients with nephrotic syndrome and its significance

Differentially Expressed Micrornas in Kidney Biopsies from Various Subtypes of Nephrotic Children.

Tissue-Specific Microrna Expression Patterns in Four Types of Kidney Disease

Study on the Levels and Clinical Significance of Serum miR-150 in Children with Nephrotic Syndrome

Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome.

Expression of serum microRNA-30a in pediatric nephrotic syndrome and its clinical significance

The serum levels of miRNAs in children with focal segmental glomerulosclerosis and children with minimal change disease

Increased Urinary Exosomal Micrornas in Children with Idiopathic Nephrotic Syndrome

Profiling and Initial Validation of Urinary Micrornas As Biomarkers in IgA Nephropathy

Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis

Expression and its clinical significance of miR-155 in serum and urine from patients with nephrolithiasis

Decreased Serum miR-503 Level in Children with Nephrotic Syndrome.

Detection of Microrna-33A-5p in Serum, Urine and Renal Tissue of Patients with IgA Nephropathy.

Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs

Glomerular Expressions of Nephrin,podocin,α-Actinin and WT1 in Children with Nephrotic Syndrome

Serum microRNAs as new diagnostic biomarkers for pre- and post-kidney transplantation.

Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.

Angiopoietin-like Protein 3: a Novel Potential Biomarker for Nephrotic Syndrome in Children

MicroRNAs in idiopathic childhood nephrotic syndrome

Urinary microRNAs are the biomarker for the disease activity of petients with focal segmental glomerulosclerosis

Expression of ANGPTL3 in children with primary nephrotic syndrome